220 related articles for article (PubMed ID: 1180576)
21. Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia type 3.
Khairi MR; Dexter RN; Burzynski NJ; Johnston CC
Medicine (Baltimore); 1975 Mar; 54(2):89-112. PubMed ID: 1117836
[TBL] [Abstract][Full Text] [Related]
22. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis.
Graze K; Spiler IJ; Tashjian AH; Melvin KE; Cervi-Skinner S; Gagel RF; Miller HH; Wolfe HJ; DeLellis RA; Leape L; Feldman ZT; Reichlin S
N Engl J Med; 1978 Nov; 299(18):980-5. PubMed ID: 692625
[TBL] [Abstract][Full Text] [Related]
23. Detection of medullary thyroid cancer by calcitonin assay in families.
Jackson CE; Tashjian AH; Block MA
Ann Intern Med; 1973 Jun; 78(6):845-52. PubMed ID: 4197369
[No Abstract] [Full Text] [Related]
24. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
Linehan WM; Farrell RE; Cooper CW; Wells SA
Surg Forum; 1977; 28():110-2. PubMed ID: 617389
[No Abstract] [Full Text] [Related]
25. [Life saving glance diagnosis in type IIb multiple endocrine neoplasia].
Biesinger E; Bootz F; Weber B
Laryngorhinootologie; 1992 Jan; 71(1):50-2. PubMed ID: 1347449
[TBL] [Abstract][Full Text] [Related]
26. [Value of the pentagastrin test in familial hypercalcitoninemia].
Bodson A; Becquevort P; Dwelshauvers J; Demol H; Michel L; Alexandre GP; Vanderbeck L
Ann Endocrinol (Paris); 1982; 43(4):299-300. PubMed ID: 7159053
[TBL] [Abstract][Full Text] [Related]
27. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
28. Medullary carcinoma of the thyroid. An update of diagnostic and prognostic factors.
Gautvik KM
Scand J Clin Lab Invest Suppl; 1991; 206():85-92. PubMed ID: 1947764
[TBL] [Abstract][Full Text] [Related]
29. Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.
Bone HG; Deftos LJ; Snyder WH; Pak CY
Henry Ford Hosp Med J; 1992; 40(3-4):258-60. PubMed ID: 1362418
[TBL] [Abstract][Full Text] [Related]
30. Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children.
Leape LL; Miller HH; Graze K; Feldman ZT; Gagel RF; Wolfe HJ; Delellis RA; Tashjian AH; Reichlin S
J Pediatr Surg; 1976 Oct; 11(5):831-7. PubMed ID: 993955
[TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid carcinoma in Sipple syndrome.
Johns Hopkins Med J; 1979 Nov; 145(5):201-6. PubMed ID: 41125
[No Abstract] [Full Text] [Related]
32. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
33. Results of a screening program for multiple endocrine neoplasia type II.
Fletcher DR; Gamvros O; MacFarlane A; Ward-McQuaid JN; Lynn J
Surg Gynecol Obstet; 1984 Aug; 159(2):119-26. PubMed ID: 6147022
[TBL] [Abstract][Full Text] [Related]
34. Medullary carcinoma of the thyroid.
Corwin TR
Surg Gynecol Obstet; 1974 Mar; 138(3):453-8. PubMed ID: 4590286
[No Abstract] [Full Text] [Related]
35. Ultrasound diagnosis of C-cell carcinoma of the thyroid.
Schwerk WB; Grün R; Wahl R
Cancer; 1985 Feb; 55(3):624-30. PubMed ID: 2856898
[TBL] [Abstract][Full Text] [Related]
36. [MEN 2A syndrome: report of a family].
Krassowski J; Gabryelewicz MB; Jeske W; Zgliczyński S
Pol Merkur Lekarski; 2000 Jul; 8(49):481-2. PubMed ID: 11070721
[TBL] [Abstract][Full Text] [Related]
37. Pediatric implications of multiple endocrine neoplasia.
Girvan DP; Holliday RL
J Pediatr Surg; 1987 Sep; 22(9):806-8. PubMed ID: 2889821
[TBL] [Abstract][Full Text] [Related]
38. Natural history of the familial medullary thyroid carcinoma-pheochromocytoma syndrome and the identification of preneoplastic stages by screening studies: a five-year report.
Gagel RF; Melvin KE; Tashjian AH; Miller HH; Feldman ZT; Wolfe HJ; DeLellis RA; Cerviskinner S; Reichlin S
Trans Assoc Am Physicians; 1975; 88():177-91. PubMed ID: 1224435
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications.
Block MA; Jackson CE; Greenawald KA; Yott JB; Tashjian AH
Arch Surg; 1980 Feb; 115(2):142-8. PubMed ID: 7356828
[TBL] [Abstract][Full Text] [Related]
40. Pentagastrin stimulation of calcitonin in pheochromocytoma does not always indicate multiple endocrine neoplasia type II.
Hein MD; Monchik JM; Jackson IM
J Endocrinol Invest; 1989 Apr; 12(4):265-7. PubMed ID: 2568375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
